UBS Group’s ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN MTUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.25K | Buy |
37
+13
| +54% | +$490 | ﹤0.01% | 9572 |
|
|
2025
Q4 | $905 | Buy |
24
+23
| +2,300% | +$876 | ﹤0.01% | 9766 |
|
|
2025
Q3 | $39 | Hold |
1
| – | – | ﹤0.01% | 10051 |
|
|
2025
Q2 | $36 | Hold |
1
| – | – | ﹤0.01% | 10077 |
|
|
2025
Q1 | $28 | Hold |
1
| – | – | ﹤0.01% | 10059 |
|
|
2024
Q4 | $30 | Hold |
1
| – | – | ﹤0.01% | 9749 |
|
|
2024
Q3 | $29 | Hold |
1
| – | – | ﹤0.01% | 9281 |
|
|
2024
Q2 | $28 | Hold |
1
| – | – | ﹤0.01% | 9281 |
|
|
2024
Q1 | $26 | Hold |
1
| – | – | ﹤0.01% | 9005 |
|
|
2023
Q4 | $19 | Hold |
1
| – | – | ﹤0.01% | 9074 |
|
|
2023
Q3 | $15 | Hold |
1
| – | – | ﹤0.01% | 9166 |
|
|
2023
Q2 | $16 | Sell |
1
-10,879
| -100% | -$168K | ﹤0.01% | 8709 |
|
|
2023
Q1 | $165K | Buy |
10,880
+8,398
| +338% | +$131K | ﹤0.01% | 5539 |
|
|
2022
Q4 | $41.8K | Buy |
2,482
+2,090
| +533% | +$34.7K | ﹤0.01% | 6938 |
|
|
2022
Q3 | $5K | Hold |
392
| – | – | ﹤0.01% | 9208 |
|
|
2022
Q2 | $6K | Buy |
+392
| New | +$6.83K | ﹤0.01% | 8700 |
|
UBS Group's MTUL Position: Q1 2026 in Review
UBS Group increased its ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN (MTUL) stake by 54% in Q1 2026, buying an estimated $490 and bringing the position to 37 shares worth $1.25K. The position accounts for ﹤0.01% of the portfolio, ranked #9572.
UBS Group first reported a position in MTUL in Q2 2022 and has held it in 16 quarters since. The position peaked at $165K in Q1 2023. 1 fund tracked by Wall St. Rank holds MTUL as of Q1 2026.
- UBS Group held 37 shares of ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN worth $1.25K as of Q1 2026.
- UBS Group bought 13 ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN shares in Q1 2026, an estimated $490.
- ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #9572 holding.
- UBS Group first reported a position in ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN in Q2 2022 and has held it in 16 quarters since.
- UBS Group's ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN position peaked at $165K in Q1 2023.
- 1 fund tracked by Wall St. Rank held ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.